Academic Education and Administration

The Inclusive Excellence Fellowship is an administrative academic postdoctoral fellowship that allows participants to gain experience in the academic environment by working as a mid-level administrator at the UNC Eshelman School of Pharmacy. The fellowship offers twelve months of postgraduate training in management, program development, teaching, and scholarship at one of the world’s leading pharmacy schools.

The School seeks a talented up-and-coming professional and promising scholar for further training in an administrative career in higher education.The fellow will support the School’s efforts to build a system of strategies to develop an inclusive and diverse pharmacy workforce.

The fellow will have the following one-year goals:

  • Enrich and diversify the University of North Carolina at Chapel Hill community by bringing talented professionals to the University
  • Develop individuals to serve in leadership roles in academia and pharmacy administration
  • Provide opportunities to design, develop, and implement innovative programming
  • Gain specialized and in-depth training within pharmacy administration
  • Foster professional development and growth, expert collaboration, career advancement, and visibility

To be considered for the Inclusive Excellence Fellowship, the candidate must

  • have received a PharmD,
  • be a graduate of an accredited U.S. school of pharmacy,
  • agree to carry out the fellowship on a full-time basis, and
  • be a citizen or a permanent resident of the United States.

The candidate must have a demonstrated experience or skill set, including but not limited to

  • superior academic performance during pharmacy school,
  • significant personal achievement,
  • leadership experience and achievement,
  • effective oral and written communication skills,
  • a high level of organization, and
  • a sincere commitment and interest in program development, management, and scholarship.

Program Director

Carla White
Assistant Dean for Innovative Leadership
Clinical Assistant Professor

  • Application deadline: We are not accepting applications at this time
  • Length: One year

This academic fellowship helps promising professionals and scholars prepare for academic careers through postgraduate training in program development, teaching, scholarship, and practice.

Program Description

Fellows will have opportunities to broaden their experience by working in an academic environment as a clinical instructor. Fellows are expected to:

  • Design, develop, and implement innovative educational content within the Pharmaceutical Care Lab (PCL)
  • Develop skills necessary to coordinate a one-semester PCL course by participating in educational workshops and guided practice with PCL faculty
  • Document and share educational innovations through publications and presentations
  • Develop skills necessary to create and sustain a compounding educational center
  • Refine clinical practice skills by maintaining a clinical practice in the inpatient or outpatient setting

The selected candidate will receive a one-year academic appointment as a fellow from July 1 to June 30 of the following year. The salary will be $40,000 annually with a health-insurance plan through UNC Student Health Services.

Program Director

Kelly L. Scolaro, PharmD
Clinical Assistant Professor, UNC Eshelman School of Pharmacy
Director, Pharmaceutical Care Lab

Scolaro has practiced in several areas, including chain community pharmacy and free clinics. She has published and presented on the topics of nonprescription therapeutics, clinical services in the community pharmacy, distance education, and skills-lab learning. She is an author and reviewer for APhA’s Handbook of Nonprescription Drugs and has been an active participant in both APhA’s Self Care Institute and P&G’s Nonprescription Medicines Academy for several years. Scolaro has a strong interest in domestic and global outreach to the underserved and has served on health outreach trips in the USA, Ecuador, Honduras, and Mexico. At UNC-Chapel Hill, she serves as the adviser for the Student Health Action Coalition outreach group, which provides disease screening services through community outreach. She is currently the chair for the AACP Self-Care and Nonprescription SIG.

About the School and the Pharmaceutical Care Lab

The UNC Eshelman School of Pharmacy is a nationally recognized leader in progressive pharmaceutical care practice, education, and research. Annually, the School educates approximately 750 professional students and more than 100 graduate students, postdocs, residents, and fellows. Its doctor of pharmacy program is ranked number two in the nation in U.S. News & World Report magazine’s 2013 edition of America’s Best Graduate Schools.

The Pharmaceutical Care Lab is an award-winning element of the School’s teaching philosophy. PharmD students begin PCL during their first week at the School, and it continues on a weekly basis until the spring of their third year. Hands-on activities and interaction drive the PCL, and students work in small groups of eight to twelve under the supervision of a senior student (for the first-year labs) and practicing clinicians (for the second- and third-year labs). This format allows students to build skills incrementally and to apply the content they learned in the classroom.

Required Qualifications

To be considered, candidates must

  • have received a terminal degree from an accredited school or college of pharmacy,
  • be licensed or be eligible for licensure in North Carolina,
  • agree to carry out the fellowship on a full-time basis, and
  • be a citizen or permanent resident of the United States.

The ideal candidate should have demonstrated experience or skill set that include, but is not limited to, superior academic performance, significant personal achievement, leadership experience, effective oral and written communication skills, strong organizational abilities, and a sincere commitment and interest in laboratory learning and program development.

To Apply

We are not accepting applications at this time.

Academic Research

This fellowship is part of the DPET fellowship program.

This two-year fellowship provides the applicant with extensive research experience in the area of cardiovascular pharmacotherapy with a special emphasis on heart failure and cardiovascular pharmacokinetics/pharmacodynamics. A multidisciplinary team approach including medicine, pharmacy, and nursing is applied to research and management of heart failure. Research protocols may include industry-sponsored clinical trials involving angiotensin II receptor blockers, beta blockers, and investigator-initiated projects involving the pharmacokinetics/pharmacodynamics of these agents. Opportunities in analytical and pharmacokinetic research are also available in addition to required coursework in study design and statistical analysis.

This fellowship is part of the DPET fellowship program.

  • Application deadline: January 1
  • Length: Two to three years
  • Accreditation: American College of Clinical Pharmacy

This fellowship program prepares highly motivated individuals to become independent researchers and academic faculty members in anti-infective clinical pharmacology. The program helps fellows develop the research expertise they need to compete for and secure research funding. Fellows will gain experience in all areas of translational research, ranging from grant writing to manuscript submission, and are expected to present research findings at scientific meetings. Research activities will focus on investigator-initiated programs.

Residency experience is strongly preferred. Appointment includes a UNC benefits package and a competitive stipend.

Program Components

  • Clinical investigations: The fellow will become proficient in the conduct of clinical investigations for both healthy-volunteer and patient populations.
  • Laboratory investigations: To further training in translational research in pharmacology, the fellow may use preclinical model systems in addition to analytical chemistry and molecular biology techniques.
  • Clinical service: This fellowship is primarily focused on developing proficiency in translational research, but limited clinical service in the UNC ID clinic is available.
  • Teaching: The fellowship will provide opportunities to develop student-teaching skills in both didactic and small, problem-based group environments.
  • Scientific meetings: The fellow will attend at least two annual scientific meetings such as ICAAC, CROI, or ASCPT. Attendance at additional meetings will be supported as abstracts are accepted for presentation.

Available Courses

  • Ethical Dilemmas in Research
  • Experimental Design Considerations in Clinical Research
  • Principles of Statistical Inference
  • Research seminar series
  • Introduction to Applied Pharmacogenomics
  • Advanced Pharmacokinetics and Pharmacodynamics
  • Drug Metabolism

Program Director

Angela Kashuba, PharmD
John A. and Deborah S. McNeill Jr. Distinguished Professor, UNC Eshelman School of Pharmacy
Adjunct Professor, UNC School of Medicine

Kashuba’s research interests include preclinical and clinical antiretroviral pharmacology, HIV therapy for treatment, prevention, and cure, and PK/PD relationships. She is director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core, and Director of the Pharmacology Core for the UNC Delaney CARE Collaboratory for HIV Eradication. She also codirects the UNC-Duke-Hamner Clinical Pharmacology T32 Fellowship program.  She is currently a member of the Advisory Committee for the NIH Office of Research on Women’s Health, the Organizing Committee for the International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, and the Organizing Committee for the International HIV and Women Workshop.

Additional Research Infrastructure at UNC-Chapel Hill

UNC Center for AIDS Research
Provides infrastructure to support investigation of HIV/AIDS using clinical and behavioral research, investigation into HIV biology and pathogenesis at the molecular level, and educational outreach.

UNC AIDS Clinical Trials Unit
Conducts and develops research into HIV infection and its associated opportunistic infections and provides access to promising clinical protocols to HIV patients.

To Apply

By January 1, submit a letter of intent, curriculum vitae, unofficial transcripts, and three letters of recommendation to:

Angela D. M. Kashuba, PharmD
UNC Eshelman School of Pharmacy
1094 Genetic Medicine Building, CB#7361
University of North Carolina at Chapel Hill
Chapel Hill, NC 27599-7569
Ph: 919-966-9998
Fax: 919-966-1020
akashuba@unc.edu

This fellowship is part of the DPET fellowship program.

  • Application deadline: Not currently recruiting for this fellowship
  • Length: Two to three years

This two- to three-year fellowship is intended to develop independent research skills for a career in academics. Experience with clinical trials (phase I pharmacokinetic, multicenter phase II-IV), preclinical model systems (cell culture), analytical techniques (HPLC) and molecular techniques (Westerns and PRC) are available. Fellowship activities include: protocol development with IRB submission, data collection and analysis with pharmacokinetic and/or statistics programs, and oral and written presentation. Coursework in advanced statistics, computer analysis, and research design is available.

The fellow will be appointed as a clinical instructor in the Department of Pharmacy Practice, with some teaching effects of malignancies, antineoplastics, and supportive care agents on CYP activity, the ability of in-vitro cell culture systems to predict in-vivo CYP interactions, pharmacokinetics of antineoplastic agents, and antiemetic research. The University of North Carolina at Chapel Hill is an NCI-certified comprehensive cancer center.

Clinical Pharmacology

The UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program is a collaboration between the University of North Carolina at Chapel Hill, Duke University, and the Hamner Institute for Drug Safety Sciences to prepare clinician-scientists to become leaders in clinical pharmacology research.

This two-year program meets the fellowship training expectations set forth by the American Board of Clinical Pharmacology and is a registered member of ABCP. We anticipate that 80 percent of our graduates will obtain board certification in clinical pharmacology.

Clinical pharmacology, in the broadest sense, encompasses drug discovery, clinical development, regulatory issues, therapeutic use and individualization of drug therapy, optimization of drug dosage regimens, an understanding of drug-induced toxicity, and measures to prevent or minimize adverse effects of drugs. This program will include both didactic and experiential training, with an emphasis in one of the following core research focus areas:

  • Drug disposition and action
  • Pharmacogenomics
  • Drug-induced organ toxicity
  • quantitative pharmacology and clinical trial design

Training will be provided in the methodology and conduct of basic and clinical research necessary to investigate the effects and mechanisms of drug actions in humans.

Trainees are expected to demonstrate competency in clinical pharmacology and to develop fundamental competency in research ethics, clinical trial design, biostatistics, and grant/manuscript preparation through required coursework and common core experiences. In addition to coursework, weekly research seminars, a journal club in the trainee’s area of research focus, and the bi-monthly Clinical Pharmacology Forum, trainees also develop competency in research methods through a translational, hypothesis-driven research experience relevant to clinical pharmacology. Fellowship trainees will devote a minimum of 80 percent of their time to research under the supervision of individual faculty mentors.

Meet Our Fellows and Our Faculty

To Apply

To obtain an application, please contact Kirsten Leysieffer at 919-843-6144 (kleysief@email.unc.edu). Applicants will submit the following:

  • Cover letter
  • Current CV
  • One-page statement of personal interests, career goals, and clinical experience
  • One-page research proposal providing an outline of the type of research that you are interested in pursuing
  • Letters of recommendation from your mentor and another professional who know your work and your research interests

Clinical Research and Drug Development

This fellowship is sponsored in collaboration with GlaxoSmithKline and is part of the DPET fellowship program.

This postdoctoral fellowship program provides training and experience in the conduct of clinical drug trials, participation in clinical research projects under the direction of a UNC faculty member and an industry preceptor, didactic instruction in courses that supplement training and professional interests, and exposure to ethical, legal, and regulatory issues in research involving investigational and marketed drugs. Fellows participate in clinical research studies with faculty at the UNC Eshelman School of Pharmacy during the first year of appointment, and with members of a drug development clinical research group (phases I–IV) at GlaxoSmithKline in the second year.

The ideal candidate should have a PharmD and possess strong analytical skills, excellent written and verbal communication skills, good organizational abilities, and evidence of leadership and team work.

Program Description

This fellowship offers participants

  • orientation to all aspects of the drug development process (e.g., pre-clinical and clinical development);
  • experience in developing, reviewing, and composing protocols, study reports and regulatory submissions;
  • exposure to the selection, setup, and monitoring of clinical sites participating in Phase I/II/III/IV and/or pharmacokinetic studies; and
  • opportunities to author abstracts, posters, and manuscripts that result from preclinical, pharmacokinetic and/or clinical studies.

The first year of the fellowship is spent at the UNC Eshelman School of Pharmacy, where training includes didactic and practical experience in drug development and clinical research. The second fellowship year will be spent at GlaxoSmithKline, where fellows participate in active projects or in-depth research.

Fellows train to develop expertise in one or more of the following areas:

  • Proposal development
  • Regulatory affairs
  • Clinical site monitoring
  • Data analysis, including PK and PD studies in healthy subjects, patient populations, or relevant in vitro/pre-clinical models
  • Drug assay methodologies
  • Biostatistical analysis

Fellows may participate in selected coursework in clinical research methods, clinical study design, biostatistics, advanced pharmacokinetics and pharmacodynamics, pharmacogenomics, data management, advanced therapeutics, drug metabolism and/or molecular biology.

About GSK

GlaxoSmithKline is one of the largest global pharmaceutical companies. The company’s mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK produces medicines that treat major disease areas, including asthma, virus control, infections, mental health, diabetes, and digestive conditions. In addition, GSK is a leader in the important area of vaccines and is developing new treatments for cancer. GSK’s Research Triangle Park location comprises nearly 5,000 employees working in state-of-the-art facilities.

Contact for Program Information

Robert Dupuis, PharmD
Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194

GSK Preceptor

Richard J. Fleck, PharmD
Therapeutic Area Head – Mature Products
US Medical Affairs

To Apply

This fellowship is not currently being offered.

This fellowship is sponsored in collaboration with PPD and is part of the DPET fellowship program.

  • Application deadline: January 1
  • Length: Two years

This postdoctoral fellowship program provides training and experience in the conduct of clinical drug trials, participation in clinical research projects under the direction of a UNC faculty member and an industry preceptor, didactic instruction in courses that supplement training and professional interests, and exposure to ethical, legal, and regulatory issues in research involving investigational and marketed drugs. Fellows participate in clinical research studies with faculty at the UNC Eshelman School of Pharmacy during the first year of appointment, and with members of a drug development clinical research group (phases I–IV) at PPD in the second year.

The ideal candidate should have a PharmD, PhD, or MD and possess strong analytical skills, excellent written and verbal communication skills, good organizational abilities, and evidence of leadership and team work.

Program Description

Year 1

Fellows will spend the first year at the University of North Carolina at Chapel Hill and will have the opportunity to:

  • participate in an original clinical research project under the direction of a clinical faculty member;
  • develop a protocol, recruit and monitor patients or subjects, coordinate clinical studies, collect and analyze data, and prepare a manuscript; and
  • gain experience with analytical methodologies, PK/PD, and pharmacogenomics; and
  • participate in selected coursework in clinical research methods, clinical study design, biostatistics, advanced PK/PD, genomics, advanced therapeutics, drug metabolism and molecular biology.

Year 2

Fellows will spend the second year in PPD offices, primarily at the Morrisville, North Carolina campus located in Research Triangle Park.

Based on the company model, the second year of the fellowship will take into account the fellows’ strengths and skills to maximize their experience with current and future business needs. Fellows will have a broad experience and will be exposed to many departments during several rotations (either sequential or parallel) that will be customized and adaptable based on each fellow’s interest areas.

The duration of each rotation is flexible and may be longitudinal depending on the fellow’s area of focus. An introductory rotation will allow fellows to gain a basic understanding of PPD’s core business.

Second-Year Rotations

Introductory Rotation: CRO Orientation/Operations

Objectives

  • Orient the fellow to all aspects of this full service CRO, including services provided (e.g., IND to NDA to post-market projects, proposal writing and development, contract preparation, budget development, and bid defense)
  • Complete Clinical Foundation Training or equivalent training necessary to complete projects successfully
  • Meet with the different departments within PPD

Expectations/Experiences

  • Gain familiarity with PPD’s corporate environment and general operations of a CRO
  • Become familiar with PPD’s different departments and their role within the organization
  • Obtain basic understanding of business development process within PPD

Departmental Rotations

Proposed Groups/Rotations

  • Clinical development/project management
  • Global product development
  • Global regulatory affairs
  • Global strategic proposal development
  • Pharmacovigilance (safety)
  • Pharmacokinetics

Objectives

  • Gain broad experience in many departments within PPD, potentially in a therapeutic area of interest
  • Work on an interdisciplinary team to consult on client development programs from Phase I to Phase IV
  • Provide medical support and drug information to global product development physicians and pharmacists or regulatory affairs professionals
  • Conduct market analysis and competitive intelligence
  • Complete a clinical trial landscape analysis of a disease state and/or drug class
  • Experience all aspects of being a member of a clinical project team dedicated to clinical study within a therapeutic area of interest
  • Assist in the project-specific training activities for the clinical project team (e.g., seminars)
  • Work independently as associate/co-project manager and lead activities of the clinical development team
  • Gain experience in investigator recruitment and feasibility
  • Review and process regulatory documents, including Case Report Form (CRF) design/protocol review
  • Witness site monitoring visits for clinical sites according to FDA regulations and PPD SOPs
  • Become trained as a clinical pharmacologist in the pharmaceutical industry setting

About PPD

PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 12,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.

PPD has offered the Drug Development and Clinical Research Fellowship since 1997 and has provided extensive training opportunities in different arenas of clinical research.

Contact for Program Information

Robert Dupuis, PharmD, BCPS
Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194
fellowships@unc.edu

PPD Preceptor

Austin Combest, PharmD, MBA
Clinical Scientist and Fellowship Director

To Apply

Visit http://pharmacydpetfellowships.web.unc.edu/ for instructions on submitting an application. The deadline for early consideration is November 15. The final deadline to apply is January 1. After you apply, you will receive a confirmation email once your application has been submitted. Following review, you may be invited to interview at UNC and on-site with fellowship sponsors. Fellowship interviews begin in early January and typically conclude in March. You will be notified of the final disposition of your application as soon as possible.

Informational Interviews

Information interviews may be arranged for the ACCP Annual Meeting and the ASHP Midyear Clinical Meeting. Potential candidates are encourages to attend these meetings to meet with UNC faculty, fellows, alumni and sponsors. We also encourage you to register for the Midyear Personnel Placement Service.

This fellowship is sponsored in collaboration with Quintiles and is part of the DPET fellowship program.

  • Application deadline: January 1
  • Length: Two years

This postdoctoral fellowship program provides training and experience in the conduct of clinical drug trials, participation in clinical research projects under the direction of a UNC faculty member and an industry preceptor, didactic instruction in courses that supplement training and professional interests, and exposure to ethical, legal, and regulatory issues in research involving investigational and marketed drugs. Fellows participate in clinical research studies with faculty at the UNC Eshelman School of Pharmacy during the first year of appointment, and with members of a drug development clinical research group (phases I–IV) at Quintiles in the second year.

The ideal candidate should have a PharmD and possess strong analytical skills, excellent written and verbal communication skills, good organizational abilities, and evidence of leadership and team work.

Program Description

Overall Goals

To provide postgraduate didactic training in

  • principles and applications of clinical drug research and development;
  • research design and methodology, including development of research protocols in the clinical investigation of new drugs and related clinical drug research methodology;
  • principles and applications of biostatistics, laboratory drug analysis, and study design methodology;
  • ethical, legal, and regulatory issues in research involving investigational and marketed drugs;
  • developing and implementing an original clinical research project in academia;
  • conducting and managing a clinical research study in industry;
  • giving seminars and scholarly presentations; and
  • performing clinical trial planning, design, operations, monitoring, data acquisition, statistical analysis, and reporting.

Broad Objectives

At the completion of the program, the fellow will be able to

  • describe the importance of clinical research in drug development;
  • describe the nature and relevance of clinical data evaluations relative to drug development;
  • understand important considerations in clinical trial design and the conduct of clinical investigations in specific patient populations;
  • conduct a clinical research study, perform the data analysis and prepare a manuscript, seminar and other scholarly vehicles for communication of the results;
  • understand the application(s) of advanced analytics and translational research to a drug development; and
  • utilize statistical analysis.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant.

Contact for Program Information

Robert Dupuis, PharmD, BCPS
Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194
fellowships@unc.edu

Quintiles Preceptor

King Jolly, PharmD
Senior Vice President, Quintiles Capital

To Apply

Visit http://pharmacydpetfellowships.web.unc.edu/ for instructions on submitting an application. The deadline for early consideration is November 15. The final deadline to apply is January 1. After you apply, you will receive a confirmation email once your application has been submitted. Following review, you may be invited to interview at UNC and on-site with fellowship sponsors. Fellowship interviews begin in early January and typically conclude in March. You will be notified of the final disposition of your application as soon as possible.

Informational Interviews

Information interviews may be arranged for the ACCP Annual Meeting and the ASHP Midyear Clinical Meeting. Potential candidates are encourages to attend these meetings to meet with UNC faculty, fellows, alumni and sponsors. We also encourage you to register for the Midyear Personnel Placement Service.

.

This fellowship is sponsored in collaboration with United Therapeutics and is part of the DPET fellowship program.

  • Application deadline: January 1
  • Length: Two years

This postdoctoral fellowship program provides training and experience in the conduct of clinical drug trials, participation in clinical research projects under the direction of a UNC faculty member and an industry preceptor, didactic instruction in courses that supplement training and professional interests, and exposure to ethical, legal, and regulatory issues in research involving investigational and marketed drugs. Fellows participate in clinical research studies with faculty at the UNC Eshelman School of Pharmacy during the first year of appointment, and with members of a drug development clinical research group (phases I–IV) at United Therapeutics in the second year.

The ideal candidate should have a PharmD and possess strong analytical skills, excellent written and verbal communication skills, good organizational abilities, and evidence of leadership and team work.

Program Description

The first year of the fellowship will be spent at the UNC Eshelman School of Pharmacy. Fellows will be mentored by UNC faculty as they participate in clinical research studies.

The second fellowship year will be spent working with researchers in the drug-development group at United Therapeutics. The company is located in the Research Triangle Park, a fifteen-minute drive from the UNC campus.

The fellowship provides

  • the opportunity to develop expertise in the conduct of clinical drug trials;
  • participation in original clinical research projects under the direction of a faculty mentor and industry preceptor;
  • didactic instruction in statistics and clinical drug design that supplements training and personal interests; and
  • exposure to in vitro and in vivo laboratory methods used to evaluate drug absorption, metabolism, and pharmacogenomics.

Fellows will learn to

  • work as part of a clinical development team responsible for the studies necessary to bring an investigational drug to market;
  • develop, review, and compose protocols, study reports, and regulatory submissions;
  • participate in the selection, setup, and monitoring of clinical sites participating in pharmacokinetic and/or Phase II/III studies;
  • answer drug-information questions from clinicians regarding approved drug products;
  • prepare abstracts, posters, and manuscripts that result from preclinical, pharmacokinetic, or Phase II/III studies; and
  • participate in projects and activities in a variety of departments, including regulatory affairs, clinical monitoring, drug safety, data management, statistics, pharmaceutical sciences, project planning and finance, and marketing (the selection of departments depends on individual fellow’s interests).

About United Therapeutics

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Currently, the company’s revenue-generating products are all in the field of cardiovascular medicine. While building business value in the cardiovascular field, the company is also laying important foundations for future franchises in the treatment of cancer and infectious diseases.

Contact for Program Information

Robert Dupuis, PharmD, BCPS
Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194
fellowships@unc.edu

United Therapeutics Preceptor

Kevin Laliberte, PharmD
Associate Vice President, Product Development

To Apply

Visit http://pharmacydpetfellowships.web.unc.edu/ for instructions on submitting an application. The deadline for early consideration is November 15. The final deadline to apply is January 1. After you apply, you will receive a confirmation email once your application has been submitted. Following review, you may be invited to interview at UNC and on-site with fellowship sponsors. Fellowship interviews begin in early January and typically conclude in March. You will be notified of the final disposition of your application as soon as possible.

Informational Interviews

Information interviews may be arranged for the ACCP Annual Meeting and the ASHP Midyear Clinical Meeting. Potential candidates are encourages to attend these meetings to meet with UNC faculty, fellows, alumni and sponsors. We also encourage you to register for the Midyear Personnel Placement Service.

The UNC Eshelman School of Pharmacy, in cooperation with UCB Biosciences, Duke University, and the Hamner Institutes for Health Sciences, sponsors a two-year fellowship in neurology and clinical drug development. This program offers an innovative combination of academic and pharmaceutical industry training that prepares fellows to launch careers in pharmaceutical medicine. Upon completion of training, fellows will have the knowledge and skills to serve as program physicians involved in academic or pharmaceutical industry neurotherapeutic projects.

Neurotherapeutics is a research area of great interest to pharmaceutical and biotech companies. The field offers promise and opportunity, and there is strong demand for physicians with training in both neurological disorders and clinical drug development.

Fellows will participate in clinical research projects with faculty at UNC and with research scientists at UCB, Duke, and the Hamner. Fellows will design, initiate, conduct and analyze research projects as part of their development programs.

Fellowship training includes:

  • An orientation to all aspects of the drug development process (e.g., preclinical and clinical development)
  • Experience in developing, reviewing, and composing protocols, study reports, and regulatory submissions
  • Exposure to the process of  selection, set-up, and monitoring of clinical sites engaged in Phase I/ II/III and/or investigator-initiated studies

Fellows will develop expertise in:

  • Proposal development
  • Drug safety and regulatory affairs
  • Clinical monitoring
  • Data analysis, including PK and PD studies in healthy subjects, patient populations, or relevant
    in vitro/pre-clinical models
  • Biostatistical analysis

Fellows may participate in selected coursework in:

  • Drug development
  • Clinical study design and research methods
  • Clinical pharmacology, biostatistics and data management
  • Pharmacokinetics and pharmacodynamics
  • Pharmacogenomics
  • Advanced therapeutics
  • Molecular biology and drug metabolism

Fellowship compensation includes:

  • A competitive stipend, health insurance, and benefits
  • An allowance for professional travel
  • Malpractice insurance

The ideal fellowship applicant will have obtained an MD and completed a US-based neurology residency or equivalent prior to the start of training. Fellows must be eligible to work in the United States and be committed to completing the two-year program.

This fellowship is part of the fellowship program offered by the Division of Pharmacotherapy and Experimental Therapeutics.

To Apply

E-mail the following information to Robert Dupuis, PharmD, at .

  • A letter describing personal goals as related to the fellowship
  • Curriculum Vitae
  • Three professional letters of reference

 

Contact for Program Information

Robert Dupuis, PharmD
Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194

Entrepreneurial Development and Global Engagement

We firmly believe that an enduring culture of innovation and entrepreneurship is rooted in gathering brilliant young scientists with great promise and placing them in an environment where the barriers to realizing bold new ideas are lowered and where they are challenged to the fullest. The Fred Eshelman Postdoctoral Fellowship for Excellence in Innovation is established to recruit the best and brightest minds across all disciplines to help advance all missions of the School. Through mentorship by members of the UNC Eshelman School of Pharmacy’s world-class faculty, Eshelman fellows are expected to either directly advance and maximize the impact of existing technologies in the School or catalyze the creation of new areas and fields of research through integration of diverse disciplines.

Fellows are selected on the basis of outstanding academic achievement, demonstrated interest in innovation and technology development, and potential to become future leaders in their fields. The fellowships are intended for those who have completed their PhD within the last five years or will have completed their PhD by June 1 of the application year. Select outstanding applicants will be invited to visit UNC Eshelman School of Pharmacy for an interview in April during which the candidates will have the opportunity to meet with faculty mentors. Award decisions will be made by April 30 of each year.

The institute will provide each fellow with an annual stipend of $60,000 and a research fund of $15,000 per year. Fellowships are awarded for up to two years. Fellows are also eligible to apply for funding through the institute.

Applicants should include the following information:

  • A fully completed Fred Eshelman Postdoctoral Fellowship for Excellence in Innovation nomination form with all required contacts, training, and demographic information.
  • A curriculum vitae.
  • A one-page summary from the applicant describing research accomplishments and impact to date.
  • A two-page letter of interest from the nominee describing their research plan and the potential impact of their research as it relates to the mission of the institute.
  • Three letters of support. The letters can be from the doctoral adviser or other scientists who mentored, supervised or collaborated with the candidate in a research setting. Letters of support should include a comparison of the candidate’s skills in relations to others at a similar stage in their career and a brief description of why the candidate can contribute significantly to the advancement of innovation in the UNC Eshelman School of Pharmacy.
  • One letter of support from a UNC Eshelman School of Pharmacy faculty member. This need not be from the eventual faculty mentor. The letter should describe the relevance of the candidate’s proposed research to the Eshelman Institute of Innovation’s mission.

Deadline for submission is February 1, 2016. A link to the online application will be available in fall 2015. Please send all inquiries to Liz Billings at liz_billings@unc.edu.

The Institute Fellowship is designed to attract and develop individuals with an entrepreneurial and innovative spirit and engage them in experiences that:

  • further the fellow’s knowledge and skills in innovation and entrepreneurship,
  • advance the work of the Institute in achieving its vision and mission,
  • immerse them in the creation and development of big ideas and ongoing, innovative work within the School and institute, and
  • position the fellow to significantly advance and accelerate innovation upon completion of the program.

Details regarding eligibility and the application process are forthcoming.

Global Engagement ultimately supports the mission of the school “to develop leaders in pharmacy education, pharmacy practice, and pharmaceutical sciences who make a difference on human health worldwide.” As the world becomes more culturally diverse in a globalized society and economy, it is necessary to train and develop the next generation of globally minded pharmacists by enabling students and faculty members to have a meaningful impact on a global scale. The Global Engagement Fellowship was created in 2013 to help enable the School’s global aspirations and to prepare global pharmacy leaders within academic institutions and healthcare organizations.

The Global Engagement Fellowship is structured as a two year training program based at the UNC Eshelman School of Pharmacy in Chapel Hill, NC. The fellow will work with and report to the Associate Dean for Entrepreneurial Development and Global Engagement (EDGE), Dhiren Thakker, PhD, in performing the following activities:

  • Initiate, evaluate, and maintain strategic international partnerships with academic institutions, governments, and health care organizations
  • Develop new and evolve current global engagement initiatives (see below)
  • Engage key university stakeholders and collaborate with other UNC health affairs schools and UNC Global
  • Identify and provide due diligence on global opportunities for students, faculty, and the School
  • Assist faculty in developing international relationships
  • Serve as a resource for School-based and inter-institutional committees on international initiatives
  • Assist in reciprocal visits by UNC and foreign delegations
  • Conduct global health and education research with faculty members at UNC and other schools and colleges of pharmacy abroad

Please review our brochure to learn more about the fellowship or contact our current fellow David Steeb at david_steeb@unc.edu with any questions or comments that you may have.

Nanotechnology

  • Application deadline:
  • Length: 24 to 36 months

Program Description

The Carolina Cancer Nanotechnology Training Program is a 24 to 36 month National Cancer Institute–sponsored T32 postdoctoral training program offered at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. The overarching goal of the CCNTP is to equip a cohort of outstanding young scientists with the multidisciplinary concepts and skills needed to improve cancer diagnosis and therapy based on concepts, tools and discoveries made in nanoscience and nanotechnology.

The CCNTP is designed to make a major contribution to the growth of the cancer nanotechnology workforce by providing both deep and broad training experiences to a highly select cohort of postdoctoral fellows. The CCNTP mentors include 22 faculty representing 11 departments in three schools at UNC Chapel Hill, including physical and materials scientists, biomedical engineers, basic biomedical scientists, pharmaceutical scientists and clinician-scientists, all of whom have demonstrated strong interests and capabilities to work at the interface between nanoscience and cancer.

Each trainee’s research will be mentored by a physical scientist and a biomedical scientist, providing a unique multifaceted training experience leading to significant contributions to cancer nanotechnology. Additionally, trainees will participate in workshops and courses that will broaden their knowledge and conceptual understanding of all areas of cancer nanotechnology. The topics of these workshops will reflect many of the major themes of the Alliance for Nanotechnology in Cancer.

CCNTP Goals

  • Provide a robust postdoctoral experience including focused didactic training and an intense cross-disciplinary mentored cancer nanotechnology research experience with established senior faculty mentors from complementary fields.
  • Provide each trainee with individualized cross-disciplinary education using innovative instructional tools:
  • Intensive training with Integrated Learning Accelerating Module in conjunction with flipped classrooms during the initial period in the program to remediate differences in backgrounds
  • Workshops and didactic courses during the subsequent training period to deepen knowledge and understanding in key areas of cancer nanotechnology research, advanced technology and translational science aspects. Each workshop will be approximately equivalent to a one credit graduate course and trainees will be expected to complete at least three workshops during two years of training. The background and interests of the trainee along with the advice of the faculty mentors will guide the choice of the workshops and courses.
  • Facilitate transition of postdoctoral fellows to independence and prepare them for the next career stage by providing them with opportunities to conduct original cancer nanotechnology research projects, apply for cancer nanotechnology pilot grants within C-CNTP and other grants available at UNC-Chapel Hill, and acquire written and oral communications skills needed to publish manuscripts in scholarly journals, report results at scientific meetings, and write successful individual extramural support applications focused on problems of cancer nanotechnology. All trainees will submit proposals for external funding in the second year of training (e.g., K99/R01, K23, K08, DoD).

Meet Our Faculty

To Apply

Candidates must be U.S. citizens, noncitizen nationals or permanent residents with evidence of superior academic performance, previous research or clinical experience and publications. To obtain an application, contact Kirsten Leysieffer at 919-843-6144. Applicants will be asked to submit the following:

  • Cover letter
  • Current CV
  • One-page statement of personal interests, career goals and clinical experience (if any)
  • At least two very strong letters of recommendation from a mentor and other professionals who know your work and your research interests

Pharmaceutical Outcomes Research

This fellowship is sponsored in collaboration with GlaxoSmithKline.

  • Application deadline: January 1
  • Length: Two years

This fellowship program will provide the training and experience needed to compete successfully for positions as a health outcomes researcher in consulting and in the pharmaceutical industry.

Preferred qualifications for the position are a PharmD, PhD or MD.  The ideal candidate should possess strong analytical skills, excellent written and verbal communication, good organizational abilities, and evidence of leadership and team work. A background in pharmaceutical outcomes research is preferred. The candidate should be self-directed and self-motivated.

The fellowship program starts July 1. The fellowship offers a competitive stipend, and provides health insurance, paid vacation, and compensation for travel to one professional meeting each year.

Program Description

First Year

The first year in the fellowship will be heavily didactic. Depending on each individual student, training will be received through enrollment in courses related to research methods, statistics, pharmacoepidemiology, pharmaceutical policy, and/or pharmacoeconomics. There will also be opportunities for fellows to design and conduct various research projects under the mentorship of faculty at the UNC Eshelman School of Pharmacy as part of the learning process.

Second Year

Fellows will spend their second year at GlaxoSmithKline in the health economics outcomes research department. Within GSK, the fellow will be exposed to the application of health outcomes research for diseases and/or medications that are relevant to the United States and will concentrate on improving the competency in generation of health outcomes evidence related to marketed pharmaceuticals in the US market.  In addition, the program will emphasize

  • strategic thinking,
  • working within a matrix environment,
  • understanding of the US payer market,
  • communications of evidence to external and internal customers,
  • handling of study budgets, and
  • study conduct.

Students may have additional opportunities to enroll in courses through UNC during the second year of their fellowship to supplement information obtained during year one.

About GSK

GlaxoSmithKline is one of the largest global pharmaceutical companies. The company’s mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK produces medicines that treat major disease areas, including cancer, asthma, virus control, infections, mental health, diabetes, and digestive conditions. In addition, GSK is a leader in the important area of vaccines and is developing new treatments for cancer. GSK’s Research Triangle Park location comprises more than 5,500 employees working in more than forty buildings on over 100 acres of land.

Contact

Gang Fang, PharmD, PhD
UNC Eshelman School of Pharmacy
2200 Kerr Hall, Campus Box # 7573
Chapel Hill, NC 27599-7573
919-966-7517

To Apply

Applicants should submit, via email, a personal statement about how a fellowship appointment would help their personal and professional growth, a curriculum vitae, official transcripts, and three professional letters of recommendation.

Applications should be e-mailed to

Shavon Carey
Division of Pharmaceutical Outcomes and Policy

Following review of application materials, applicants may be invited to interview at UNC and GSK. The School will facilitate travel to Chapel Hill for applicants invited to interview. Interviews will be held in February and conclude in March, and applicants will be notified of the final decision about their applications as soon as possible.

Pharmacokinetics/Pharmacodynamics

This fellowship is sponsored in collaboration with GlaxoSmithKline and is part of the DPET fellowship program.

  • Application deadline:This fellowship is not currently being offered.
  • Length: Two year

This postdoctoral fellowship program provides research experience that enables fellows to gain expertise in drug development, quantitative pharmacology, translational research, and pharmacometrics while preparing them for careers as clinical pharmacologists, clinical pharmacokineticists, or pharmacometricians in an industrial, academic, or regulatory setting.

The ideal candidate should have a PharmD, PhD, or MD and possess strong analytical skills, excellent written and verbal communication skills, good organizational abilities, and evidence of leadership and team work. A background in pharmacokinetics is preferred.

Program Description

First Year

Fellows will participate in clinical pharmacology and drug-transport and metabolism studies with faculty at the UNC Eshelman School of Pharmacy. Each fellow will design, initiate, conduct, and analyze various research projects as part of the learning experience. Fellows also will enroll in advanced courses on pharmacokinetics/pharmacodynamics and clinical research methods and may attend additional courses such as biostatistics, advanced therapeutics, drug metabolism, and molecular biology.

Second Year

Fellows will work at GlaxoSmithKline, applying state-of-the-art quantitative methodologies to the development of compounds in the GSK portfolio, such as population pharmacokinetic and pharmacodynamic analyses, exposure-response, disease progression modeling, and clinical trial simulations. Fellows will contribute to the design and analysis of first-time-in-human, proof-of-concept, drug-drug interaction, or other clinical pharmacology studies. They will use advanced techniques as they participate in modeling and simulation efforts for quantitative decision making.

UNC Preceptors

Kim L. R. Brouwer, PharmD, PhD
William R. Kenan Jr. Distinguished Professor
Brouwer directs an NIH-funded research program focused on hepatobiliary drug disposition and development and refinement of in vitro model systems to predict in vivo hepatobiliary disposition, drug interactions, and hepatotoxicity.

Julie Dumond, PharmD, MS
Assistant Professor
Dumond’s research interests include pharmacokinetic and pharmacodynamic properties of antiretroviral drugs.

GSK Preceptor

Brendan Johnson, PhD
Johnson is a director of clinical pharmacology and simulation at GSK. The company is committed to model-based approaches to enhance the quality and efficiency of drug development. Johnson has worked in this research area since completing this fellowship in 2005.

About GSK

GlaxoSmithKline is one of the largest global pharmaceutical companies. The company’s mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK produces medicines that treat major disease areas, including cancer, asthma, virus control, infections, mental health, diabetes, and digestive conditions. In addition, GSK is a leader in the important area of vaccines and is developing new treatments for cancer. GSK’s Research Triangle Park location comprises more than 5,500 employees working in over forty buildings on more than 100 acres of land.

Contact for Program Information

Robert Dupuis, PharmD, BCPS
Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194
fellowships@unc.edu

To Apply

This fellowship is not currently being offered.

This fellowship is sponsored in collaboration with Quintiles and is part of the DPET fellowship program.

  • Application deadline: January 1
  • Length: Two years

Th clinical pharmacokinetics/pharmacodynamics postdoctoral fellowship program at Quintiles provides research experience that enables fellows to gain expertise in drug development, quantitative pharmacology, translational research, or pharmacometrics while preparing them for careers as clinical pharmacologists, clinical pharmacokineticists, or pharmacometricians in an industrial, academic, or regulatory setting.

The ideal candidate should have a PharmD, PhD, or MD and possess strong analytical and programming skills, excellent written and verbal communication skills, good organizational abilities, and evidence of leadership and team work. A background in pharmacokinetics is preferred.

Program Description

Fellows will participate in clinical pharmacokinetic, pharmacodynamic, transport, and/or metabolism studies with faculty at the School and with members of the Clinical Pharmacokinetics group at Quintiles. Each fellow will design and initiate an individual research project over the course of the two-year fellowship. Fellows will spend their first year at the School and their second year at Quintiles.

Fellows will develop expertise in one or more of the following areas:

  • Design and implementation of PK and PD studies in healthy volunteers, patient populations, or relevant in vitro/pre-clinical models
  • Computer PK and PD data analysis and simulations
  • Laboratory methods to evaluate clinical drug disposition problems
  • Biostatistical analysis and pharmacometrics

Fellows may participate in selected course work in biostatistics, advanced pharmacokinetics and pharmacodynamics, clinical research methods, clinical study design, data management, advanced therapeutics, drug metabolism, and/or molecular biology.

The fellowship provides a competitive stipend, health insurance, and professional travel.

UNC Preceptors

Kim L. R. Brouwer, PharmD, PhD
William R. Kenan Jr. Distinguished Professor
Brouwer directs an NIH-funded research program focused on hepatobiliary drug disposition and development and refinement of in vitro model systems to predict in vivo hepatobiliary disposition, drug interactions, and hepatotoxicity.

Julie Dumond, PharmD, MS
Assistant Professor
Dumond’s research interests include pharmacokinetic and pharmacodynamic properties of antiretroviral drugs.

Quintiles Preceptors

Laurence Levasseur, PhD
Levasseur leads the PK/PD group in the Clinical Pharmacology Department at Quintiles. Her research interests include population pharmacokinetics, and PK/PD modeling and simulation.

Seth Berry, PharmD
Berry is the director of the Clinical PK/PD Modeling and Simulation Group in the Clinical Pharmacology Department at Quintiles. His research interests include population PK/PD modeling and simulation, D-optimal design, and clinical trial simulation. Berry has worked in this research area since completing this fellowship in 2002.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant.

Contact for Program Information

Robert Dupuis, PharmD, BCPS
Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194
fellowships@unc.edu

To Apply

Visit http://pharmacydpetfellowships.web.unc.edu/ for instructions on submitting an application. The deadline for early consideration is November 15. The final deadline to apply is January 1. After you apply, you will receive a confirmation email once your application has been submitted. Following review, you may be invited to interview at UNC and on-site with fellowship sponsors. Fellowship interviews begin in early January and typically conclude in March. You will be notified of the final disposition of your application as soon as possible.

Informational Interviews

Information interviews may be arranged for the ACCP Annual Meeting and the ASHP Midyear Clinical Meeting. Potential candidates are encourages to attend these meetings to meet with UNC faculty, fellows, alumni and sponsors. We also encourage you to register for the Midyear Personnel Placement Service.

Regulatory Affairs

This fellowship is sponsored in collaboration with GlaxoSmithKline and is part of the DPET fellowship program.

  • Application deadline: January 1
  • Length: Two years

This fellowship provides practical training and experience in key regulatory functions to help fellows gain expertise in the regulatory requirements of drug development. The fellowship is designed to include rotations that will provide fellows the opportunity to work in academic/hospital, pharmaceutical, and regulatory settings as part of their training. Overall this program should enhance fellows’ knowledge and real-world experience and develop regulatory practitioners prepared for the pharmaceutical industry or academia/hospital practice.

The fellowship sponsors intend for fellows to train with the UNC Eshelman School of Pharmacy and UNC Hospitals and GlaxoSmithKline in Research Triangle Park, North Carolina. There is also potential to gain experience in agency aspects of regulatory and regulatory science (ex. PhRMA or similar organizations). The fellows will spend six months at UNC and twelve to eighteen months in the Global Regulatory Affairs Department at GlaxoSmithKline.

Program Description

The fellowship will provide postgraduate didactic training in

  • US, European Union, and Canadian regulations, guidelines, and policies;
  • principles and applications of pharmaceutical product development and evaluation;
  • research design and methodology, including development of research protocols in support of successful marketing driven programs; and
  • leadership behaviors.

Additionally, the fellowship will provide postgraduate experience in

  • the requirements and mechanics of Investigational New Drug, New Drug Application, and maintenance submissions;
  • regulatory strategy development, use and interpretation of regulations and guidelines, and interaction with regulatory agencies;
  • principles of regulatory agency review processes in the US, Europe, emerging markets, Asia Pacific, and Canada;
  • critical assessment of drug packages in pharmaceutical and clinical settings; and
  • seminars and scholarly presentations.

At the end of the fellowship, fellows should have developed knowledge of

  • the pharmaceutical industry;
  • PhRMA and regulatory agencies;
  • the drug-development process;
  • regulatory agency guidelines and expectations; and
  • business competencies such as analytical reasoning and communication skills, problem solving, team working, relationship building, working flexibly, and influencing.

The fellowship will also emphasize the development of critical and strategic thinking skills, as well as leadership behaviors.

About GlaxoSmithKline

GlaxoSmithKline is one of the largest global pharmaceutical companies. The company’s mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK produces medicines that treat major disease areas, including asthma, virus control, infections, mental health, diabetes, and digestive conditions. In addition, GSK is a leader in the important area of vaccines and is developing new treatments for cancer. GSK’s Research Triangle Park location comprises nearly 5,000 employees working in state-of-the-art facilities.

Contact for Program Information

Robert Dupuis, PharmD, BCPS
Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194
fellowships@unc.edu

To Apply

Visit http://pharmacydpetfellowships.web.unc.edu/ for instructions on submitting an application. The deadline for early consideration is November 15. The final deadline to apply is January 1. After you apply, you will receive a confirmation email once your application has been submitted. Following review, you may be invited to interview at UNC and on-site with fellowship sponsors. Fellowship interviews begin in early January and typically conclude in March. You will be notified of the final disposition of your application as soon as possible.

Informational Interviews

Information interviews may be arranged for the ACCP Annual Meeting and the ASHP Midyear Clinical Meeting. Potential candidates are encourages to attend these meetings to meet with UNC faculty, fellows, alumni and sponsors. We also encourage you to register for the Midyear Personnel Placement Service.

The University of North Carolina at Chapel Hill is an equal opportunity, affirmative action employer and welcomes all to apply regardless of race, color, gender, national origin, age, religion, genetic information, sexual orientation, gender identity or gender expression. We also encourage protected veterans and individuals with disabilities to apply.